Ask About Your Case

What are fda reports?

Yaz Lawsuits

Trouble with Yaz Advertisements: Has FDA Recalled Yaz?

Pity the poor female consumer. In this case women who liked what they heard on TV and read in magazines, asked their doctors to prescribe Yaz birth control pills.

The Yaz advertisements enticed millions of bright women who wanted to find a solution to PMS and acne. Now thousands of women have filed lawsuits claiming that Yaz birth control failed to warm women that this brand had increased risks of blood clots which can cause potentially fatal strokes or pulmonary embolisms. Women have died including young women.

In October 2008, the FDA wrote a warning letter to Bayer, informing that ads for Yaz were misleading because Yaz was never approved to treat acne and PMS as the Yaz advertisements suggested.

Yaz was approved for the less serious afflictions of moderate acne and pre-menstrual dysphoric disorder (PMSD). The Yaz lawsuits claim that Bayer's advertising attracted patients who never should have used Yaz, who should've used a safer alternative.

Bayer entered into a unique settlement with a group of state attorney generals. The agreement required the company to spend $20 million on corrective advertising and to submit all future ads for Yaz to the FDA for preapproval.

Twenty million dollars is nothing to Bayer. They know better. Bayer has a history of misleading Yaz advertisements and claims to the consumer.

Has Yaz been recalled? No!

Read the Side Effect of Yasmin reported in the FDA reports.

Source: http://www.brandweek.com/bw/content_display/current-issue/e3i8b177543696059c91a3ce72f8add34ee

Yaz Related Deep Vein Thrombosis

Fda Warns About Misleading Advertising Of Yaz

Symptoms Of Deep Vein Thrombosis

New Study Indicates Increased Risk Of Blood Clots For Yaz And Yasmin Users

Fda Advisory Panel To Review Yaz Safety

New Information Comes Out In Bayer Yasmin Case

Fda Approves Generic Form Of Yaz Week Before Scheduled Yaz Hearing

Fda Panel Recommends Changes For Yaz